Omnicell (OMCL) Restructuring Costs (2010 - 2022)
Omnicell (OMCL) reported Restructuring Costs of $3.5 million for Q1 2022, up 75.0% year-over-year from $2.0 million in Q1 2021, and up 75.0% on a QoQ basis from $2.0 million in Q1 2021.
Omnicell (OMCL) has 3 years of Restructuring Costs data on file, last reported at $3.5 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 3.50 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Sep 30, 2010 | 1.20 Mn |